These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of TOPCAT Trial. Merrill M, Sweitzer NK, Lindenfeld J, Kao DP. JACC Heart Fail; 2019 Mar; 7(3):228-238. PubMed ID: 30819379 [Abstract] [Full Text] [Related]
5. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial. Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, O'Meara E, Desai AS, Heitner JF, Li G, Fang J, Rouleau J, Zile MR, Markov V, Ryabov V, Reis G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD. Circ Heart Fail; 2014 Sep; 7(5):740-51. PubMed ID: 25122186 [Abstract] [Full Text] [Related]
6. Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study. Vazir A, Claggett B, Pitt B, Anand I, Sweitzer N, Fang J, Fleg J, Rouleau J, Shah S, Pfeffer MA, Solomon SD. JACC Heart Fail; 2017 Nov; 5(11):782-791. PubMed ID: 29032132 [Abstract] [Full Text] [Related]
7. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial. Cikes M, Claggett B, Shah AM, Desai AS, Lewis EF, Shah SJ, Anand IS, O'Meara E, Rouleau JL, Sweitzer NK, Fang JC, Saksena S, Pitt B, Pfeffer MA, Solomon SD. JACC Heart Fail; 2018 Aug; 6(8):689-697. PubMed ID: 30007557 [Abstract] [Full Text] [Related]
9. Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial. Lewis EF, Claggett B, Shah AM, Liu J, Shah SJ, Anand I, O'Meara E, Sweitzer NK, Rouleau JL, Fang JC, Desai AS, Retta TM, Solomon SD, Heitner JF, Stamos TD, Boineau R, Pitt B, Pfeffer MA. Circ Heart Fail; 2018 Mar; 11(3):e004457. PubMed ID: 29664406 [Abstract] [Full Text] [Related]
11. Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function. Beldhuis IE, Myhre PL, Bristow M, Claggett B, Damman K, Fang JC, Fleg JL, McKinlay S, Lewis EF, O'Meara E, Pitt B, Shah SJ, Vardeny O, Voors AA, Pfeffer MA, Solomon SD, Desai AS. J Am Coll Cardiol; 2021 Mar 09; 77(9):1211-1221. PubMed ID: 33663739 [Abstract] [Full Text] [Related]
12. Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction. Selvaraj S, Claggett B, Shah SJ, Anand I, Rouleau JL, O'Meara E, Desai AS, Lewis EF, Pitt B, Sweitzer NK, Fang JC, Pfeffer MA, Solomon SD. Circ Heart Fail; 2018 Nov 09; 11(11):e005288. PubMed ID: 30571191 [Abstract] [Full Text] [Related]
13. Time-averaged cumulative blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: analysis from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. Huang R, Wu R, Lin Y, Zhong X, Ye X, Zhuang X, Liao X. J Hypertens; 2022 Oct 01; 40(10):1918-1926. PubMed ID: 36018222 [Abstract] [Full Text] [Related]
16. Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction. Rossignol P, Claggett BL, Liu J, Vardeny O, Pitt B, Zannad F, Solomon S. Am J Hypertens; 2018 Mar 10; 31(4):407-414. PubMed ID: 29228101 [Abstract] [Full Text] [Related]
17. Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. Shen L, Jhund PS, Docherty KF, Petrie MC, Anand IS, Carson PE, Desai AS, Granger CB, Komajda M, McKelvie RS, Pfeffer MA, Solomon SD, Swedberg K, Zile MR, McMurray JJV. JACC Heart Fail; 2019 May 10; 7(5):418-427. PubMed ID: 30981744 [Abstract] [Full Text] [Related]